Cargando…
New immunological potential markers for triple negative breast cancer: IL18R1, CD53, TRIM, Jaw1, LTB, PTPRCAP
Breast cancer (BC) is the second leading cause of cancer death in women worldwide, and settings of specific prognostic factors and efficacious therapies are made difficult by phenotypic heterogeneity of BC subtypes. Therefore, there is a current urgent need to define novel predictive genetic predict...
Autores principales: | Marchetti, Paolo, Antonov, Alexey, Anemona, Lucia, Vangapandou, Chaitania, Montanaro, Manuela, Botticelli, Andrea, Mauriello, Alessandro, Melino, Gerry, Catani, M. Valeria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777524/ https://www.ncbi.nlm.nih.gov/pubmed/35201443 http://dx.doi.org/10.1007/s12672-021-00401-0 |
Ejemplares similares
-
No Time to Die: How Kidney Cancer Evades Cell Death
por: Ganini, Carlo, et al.
Publicado: (2022) -
ΔNp63 promotes IGF1 signalling through IRS1 in squamous cell carcinoma
por: Frezza, Valentina, et al.
Publicado: (2018) -
ZNF281/Zfp281 is a target of miR‐1 and counteracts muscle differentiation
por: Nicolai, Sara, et al.
Publicado: (2019) -
Increased Sympathetic Renal Innervation in Hemodialysis Patients Is the Anatomical Substrate of Sympathetic Hyperactivity in End‐Stage Renal Disease
por: Mauriello, Alessandro, et al.
Publicado: (2015) -
In Vivo Identification of H3K9me2/H3K79me3 as an Epigenetic Barrier to Carcinogenesis
por: Piro, Maria Cristina, et al.
Publicado: (2023)